Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
m 03:43 | Cytarabine (Ara-C) diffhist +156 Jwarner talk contribs →History of changes in PMDA indication |
03:36 | Mantle cell lymphoma diffhist +1,367 Jwarner talk contribs →Obinutuzumab monotherapy {{#subobject:7f1090|Regimen=1}} |
30 May 2024
|
m 23:32 | Breast cancer 2 changes history -33 [Warner-admin (2×)] | |||
m |
|
23:32 (cur | prev) -1 Warner-admin talk contribs Text replacement - "Mitomycine" to "Mitomycin" | |||
m |
|
23:12 (cur | prev) -32 Warner-admin talk contribs |
|
23:22 | Diffuse large B-cell lymphoma 2 changes history +209 [Warner-admin; Jwarner] | |||
|
23:22 (cur | prev) +9 Warner-admin talk contribs | ||||
m |
|
14:13 (cur | prev) +200 Jwarner talk contribs |
m 17:36 | CNS lymphoma diffhist +3,516 Jwarner talk contribs →Methotrexate-Cytarabine {{#subobject:f24bde|Regimen=1}} |
28 May 2024
m 23:12 | Allogeneic HSCT diffhist +605 Jwarner talk contribs →References |
|
m 20:58 | Follicular lymphoma 6 changes history +5,127 [Jwarner (6×)] | |||
m |
|
20:58 (cur | prev) +1,006 Jwarner talk contribs →Rituximab monotherapy {{#subobject:ea91fc|Regimen=1}} | |||
m |
|
00:42 (cur | prev) +537 Jwarner talk contribs →R-CVP {{#subobject:dff264|Regimen=1}} | |||
m |
|
00:41 (cur | prev) +991 Jwarner talk contribs →R-CVP {{#subobject:dff264|Regimen=1}} | |||
m |
|
00:33 (cur | prev) +161 Jwarner talk contribs | |||
m |
|
00:29 (cur | prev) +1,216 Jwarner talk contribs →R-CHOP {{#subobject:cd6d2c|Regimen=1}} | |||
m |
|
00:27 (cur | prev) +1,216 Jwarner talk contribs →Bendamustine & Rituximab (BR) {{#subobject:981d90|Regimen=1}} |
|
19:46 | Mantle cell lymphoma 4 changes history +13,776 [Jwarner (4×)] | |||
|
19:46 (cur | prev) +8,011 Jwarner talk contribs →R-CHOP {{#subobject:ca52ab|Regimen=1}} | ||||
m |
|
19:40 (cur | prev) +136 Jwarner talk contribs →R-CHOP/R-DHAP {{#subobject:989434|Regimen=1}} | |||
m |
|
19:39 (cur | prev) +137 Jwarner talk contribs →R-CHOP/R-DHAOx {{#subobject:98ox34|Regimen=1}} | |||
|
19:36 (cur | prev) +5,492 Jwarner talk contribs →R-CHOP/R-DHAP {{#subobject:989434|Regimen=1}} |
26 May 2024
|
m 13:15 | Follicular lymphoma 2 changes history +1,992 [Jwarner (2×)] | |||
m |
|
13:15 (cur | prev) +1,053 Jwarner talk contribs →Rituximab monotherapy {{#subobject:ea91fc|Regimen=1}} | |||
m |
|
12:54 (cur | prev) +939 Jwarner talk contribs →R-CVP {{#subobject:dff264|Regimen=1}} |
m 12:55 | Rituximab (Rituxan) diffhist -13 Jwarner talk contribs →Also known as |
25 May 2024
24 May 2024
|
m 13:43 | Breast cancer 6 changes history -18,104 [Jwarner (6×)] | |||
m |
|
13:43 (cur | prev) 0 Jwarner talk contribs →Metastatic disease, first-line chemotherapy | |||
m |
|
13:41 (cur | prev) +148 Jwarner talk contribs →Adjuvant chemotherapy | |||
m |
|
13:40 (cur | prev) +96 Jwarner talk contribs →Adjuvant therapy, sequential regimens | |||
m |
|
13:30 (cur | prev) +1,190 Jwarner talk contribs →FEC {{#subobject:3613b7|Regimen=1}} | |||
m |
|
13:24 (cur | prev) -19,616 Jwarner talk contribs →Cyclophosphamide & Doxorubicin (AC) {{#subobject:77b0fd|Regimen=1}} | |||
m |
|
11:21 (cur | prev) +78 Jwarner talk contribs →References |
23 May 2024
|
17:41 | Follicular lymphoma 5 changes history +3,820 [Jwarner (5×)] | |||
m |
|
17:41 (cur | prev) +26 Jwarner talk contribs →Zanubrutinib & Obinutuzumab (ZO) {{#subobject:942zo7|Regimen=1}} | |||
m |
|
17:40 (cur | prev) +1,822 Jwarner talk contribs →Obinutuzumab monotherapy {{#subobject:942df7|Regimen=1}} | |||
m |
|
17:36 (cur | prev) +1,972 Jwarner talk contribs →Rituximab monotherapy {{#subobject:8fecee|Regimen=1}} | |||
m |
|
17:36 (cur | prev) -1,973 Jwarner talk contribs →Obinutuzumab & Zanubrutinib (ZO) {{#subobject:942zo7|Regimen=1}} | |||
|
17:35 (cur | prev) +1,973 Jwarner talk contribs →Obinutuzumab monotherapy {{#subobject:942df7|Regimen=1}} |
m 12:57 | Mantle cell lymphoma diffhist +676 Jwarner talk contribs →Bendamustine & Rituximab (BR) {{#subobject:b7779c|Regimen=1}} |
m 12:06 | Breast cancer diffhist +3,930 Jwarner talk contribs |
20 May 2024
|
m 17:14 | Mantle cell lymphoma 3 changes history +757 [Jwarner (3×)] | |||
m |
|
17:14 (cur | prev) +9 Jwarner talk contribs →Rituximab monotherapy {{#subobject:712b01|Regimen=1}} | |||
m |
|
17:10 (cur | prev) +178 Jwarner talk contribs →Regimen variant #4, 18 doses {{#subobject:572f85|Variant=1}} | |||
m |
|
17:08 (cur | prev) +570 Jwarner talk contribs →References |
m 13:28 | Study Groups diffhist -1 Jwarner talk contribs →Main table |
19 May 2024
|
m 01:07 | Diffuse large B-cell lymphoma 2 changes history +66 [Jwarner (2×)] | |||
m |
|
01:07 (cur | prev) +21 Jwarner talk contribs →R-ESHAP {{#subobject:7794d|Regimen=1}} | |||
m |
|
01:05 (cur | prev) +45 Jwarner talk contribs →Regimen {{#subobject:b6038c|Variant=1}} |
m 00:38 | Mantle cell lymphoma diffhist +17 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} |
18 May 2024
m 11:50 | Acute myeloid leukemia diffhist +292 Jwarner talk contribs →CLAG {{#subobject:702383|Regimen=1}} |
|
m 01:16 | Acute promyelocytic leukemia 3 changes history +206 [Jwarner (3×)] | |||
m |
|
01:16 (cur | prev) +17 Jwarner talk contribs →ATRA monotherapy {{#subobject:45c33c|Regimen=1}} | |||
m |
|
01:13 (cur | prev) +94 Jwarner talk contribs | |||
m |
|
01:12 (cur | prev) +95 Jwarner talk contribs →Regimen variant #3, 0.3/45 {{#subobject:e391b9|Variant=1}} |
17 May 2024
m 18:28 | Follicular lymphoma diffhist +636 Jwarner talk contribs |
m 18:25 | Diffuse large B-cell lymphoma diffhist +468 Jwarner talk contribs →References |
|
m 16:21 | Breast cancer 2 changes history -12 [Jwarner (2×)] | |||
m |
|
16:21 (cur | prev) +5 Jwarner talk contribs | |||
m |
|
16:15 (cur | prev) -17 Jwarner talk contribs |